Respiratory papillomatosis - Symptoms, Causes, Treatment & Prevention

```html

Overview

Respiratory papillomatosis (RP), also called recurrent respiratory papillomatosis (RRP), is a rare condition in which benign (“wart‑like”) growths called papillomas develop in the lining of the airway. These lesions most often arise in the larynx (voice box) but can spread to the trachea, bronchi, and even the lungs.

RP is caused by infection with certain types of human papillomavirus (HPV), most frequently HPV‑6 and HPV‑11. Although the papillomas are non‑cancerous, they can obstruct the airway, cause chronic hoarseness, and lead to serious breathing problems.

Who it affects

• Children: About 60‑80 % of cases present before age 5 (juvenile RRP). The disease is usually acquired at birth when a baby passes through an infected birth canal.
• Adults: Adult‑onset RRP accounts for the remaining 20‑40 % of cases and is often linked to sexual acquisition of HPV.

Prevalence

RRP is considered an orphan disease. In the United States, the incidence is estimated at 4–5 new cases per 100,000 children per year, translating to roughly 2,500–3,000 new pediatric cases annually. Adult‑onset cases are less common, with an estimated incidence of 1–2 per 100,000 adults each year. The condition occurs worldwide, without a clear racial or ethnic predilection.

---

Symptoms

Because papillomas can grow anywhere in the airway, the clinical picture varies. Below is a comprehensive list of reported symptoms, grouped by the region most often affected.

Upper airway (larynx, vocal cords)

• Hoarseness or weak voice: The most common early sign, especially in children.
• Stridor: A high‑pitched, wheezing sound heard during inhalation, indicating airway narrowing.
• Chronic cough: Often dry and worse with exertion.
• Difficulty swallowing (dysphagia): Large lesions may interfere with the passage of food.
• Voice fatigue: Voice becomes more hoarse after talking.

Lower airway (trachea, bronchi, lungs)

• Wheezing: Particularly during exhalation.
• Shortness of breath (dyspnea): May be progressive.
• Recurrent respiratory infections: Papillomas can trap secretions, fostering bacterial growth.
• Chest pain or discomfort: Rare but reported when lesions are large.
• Hemoptysis (coughing up blood): Usually mild but warrants evaluation.

Systemic / less common symptoms

• Ear pain or recurrent ear infections (when eustachian tube involvement occurs).
• Weight loss or failure to thrive in infants due to chronic feeding difficulty.
• Occasional fever associated with secondary infections.

---

Causes and Risk Factors

RRP is an HPV‑related disease. The virus infects the basal cells of the respiratory epithelium, leading to uncontrolled proliferation.

Primary cause

• Human papillomavirus (HPV) types 6 and 11: Low‑risk strains that cause genital warts also cause the majority of RRP cases.

How infection occurs

• Perinatal transmission: The most common route for juvenile RRP. An infant passes through the birth canal of a mother with active genital HPV infection, especially if she has visible warts.
• Sexual transmission: In adults, oral‑genital contact can spread the virus to the respiratory mucosa.
• Rare nosocomial or iatrogenic spread: Documented cases after tracheostomy or endoscopic procedures.

Risk factors

• Maternal HPV infection at the time of delivery (especially with visible genital warts).
• Cesarean delivery does not completely eliminate risk but reduces it compared with vaginal birth when the mother is infected.
• Early sexual activity or multiple oral-genital partners (adult‑onset RRP).
• Immunosuppression (e.g., HIV infection, organ transplantation) can increase lesion growth rate.
• Smoking exposure may exacerbate airway irritation, though it is not a direct cause.

---

Diagnosis

Timely diagnosis is essential because airway obstruction can progress quickly.

Clinical evaluation

• Detailed history focusing on voice changes, breathing difficulty, and any maternal HPV infection.
• Physical exam including flexible nasolaryngoscopy (a thin fiber‑optic scope passed through the nose to view the larynx).

Diagnostic tests

• Direct laryngoscopy & biopsy: Performed under general anesthesia; tissue samples confirm papilloma histology and allow HPV typing.
• Imaging:
  • CT scan of the neck/chest: Helps delineate the extent of disease, especially for subglottic or lung involvement.
  • MRI: Useful for assessing soft‑tissue spread without radiation.
• HPV DNA testing: PCR on biopsy tissue determines the viral genotype, which can influence prognosis (HPV‑11 is associated with a more aggressive course).
• Pulmonary function tests: Baseline assessment for patients with lower‑airway disease.

Differential diagnosis

Conditions that can mimic RP include vocal cord nodules, laryngeal hemangioma, granulomas, and early laryngeal cancer. Biopsy is the definitive way to differentiate.

---

Treatment Options

There is currently no cure for the underlying viral infection, so management focuses on controlling lesion growth, preserving airway patency, and maintaining voice quality.

1. Surgical interventions

• Microlaryngoscopic excision (cold knife, laser, or micro‑debrider): The mainstay of therapy. Repeated procedures are often required every 3–12 months.
• CO₂ laser ablation: Precise removal with minimal bleeding; suitable for accessible lesions.
• Potassium titanyl phosphate (KTP) laser: Offers good hemostasis and is effective for subglottic disease.
• Micro‑debrider: Allows bulk removal while preserving surrounding tissue.
• Tracheostomy: Reserved for life‑threatening obstruction when upper‑airway surgery cannot rapidly relieve blockage.

2. Adjuvant medical therapies

• Intralesional cidofovir: An antiviral nucleotide analogue injected directly into papillomas. Meta‑analyses show modest reduction in recurrence rates, but nephrotoxicity requires monitoring.
• Bevacizumab (Avastin): Anti‑VEGF agent used intralesionally or systemically; early studies demonstrate decreased lesion size and surgical frequency.
• Interferon‑α: Historically used, now less common due to flu‑like side effects.
• HPV therapeutic vaccines (e.g., VGX‑3100, HPV‑16/18 E7 vaccine): Investigational; phase II trials show promise in reducing disease burden.

3. Systemic therapies (selected cases)

• Systemic bevacizumab infusions have been reported to shrink lung papillomas and improve pulmonary function in refractory adult cases.
• Immune modulators such as pembrolizumab (PD‑1 inhibitor) have been explored in malignant transformation, not routine RP.

4. Supportive measures & lifestyle

• Voice therapy: Conducted by a speech‑language pathologist to improve vocal technique and reduce strain.
• Humidified air: Helps keep airway secretions thin, easing breathing.
• Avoidance of irritants: Tobacco smoke, vaping, and strong chemical fumes can exacerbate lesions.
• Nutritional support: Important for children with feeding difficulties; may require dietitian referral.

5. Follow‑up schedule

Because recurrence is the rule rather than the exception, patients typically see an otolaryngologist every 3–6 months, with more frequent visits after surgery or when symptoms change.

---

Living with Respiratory Papillomatosis

RRP is a chronic condition; coping strategies focus on airway safety, voice preservation, and emotional well‑being.

Daily management tips

• Hydration: Drink plenty of water; aim for at least 8 glasses daily to keep secretions thin.
• Humidify indoor air: Use a cool‑mist humidifier, especially during winter.
• Gentle voice use: Speak softly, avoid shouting, and take vocal rest breaks throughout the day.
• Air quality: Keep home smoke‑free, limit exposure to dust, pet dander, and strong fragrances.
• Regular exercise: Low‑impact aerobic activity (e.g., walking, swimming) supports overall lung health without over‑taxing the airway.
• Vaccination: Ensure up‑to‑date influenza and COVID‑19 vaccines to reduce risk of secondary infections.
• Medical diary: Record voice changes, breathing difficulty, and any triggers; share with your ENT at each visit.

Psychosocial support

• Connect with support groups (e.g., RRP Foundation, local patient advocacy groups).
• Consider counseling or psychotherapy, especially for children who may experience isolation due to voice differences.
• School accommodations: Provide a note to teachers for voice rest periods and possible speech‑therapy services.

When traveling

• Carry a copy of your medical summary, including recent imaging and the name of the treating surgeon.
• Bring a portable humidifier or saline nasal spray for dry airplane cabins.
• Identify the nearest hospital with ENT services at your destination.

---

Prevention

Because the disease originates from HPV infection, primary prevention targets the virus.

• HPV vaccination: The 9‑valent vaccine (Gardasil 9) protects against HPV 6 and 11, the strains responsible for >90 % of RRP. Routine vaccination at ages 11–12 (can start as early as 9) is strongly recommended by the CDC and WHO.
• Maternal screening & treatment: Pregnant women with genital warts should discuss treatment options with obstetric providers. While treatment during pregnancy is limited, awareness helps inform delivery planning.
• Safe sexual practices: Using barrier protection during oral sex reduces the risk of adult‑onset transmission.
• Hand hygiene: Reduces spread of HPV from genital to oral sites in household settings.
• Avoid unnecessary airway instrumentation: When possible, limit repeated intubations or bronchoscopy that could seed virus.

---

Complications

If left untreated or inadequately controlled, RP can lead to significant morbidity.

• Airway obstruction: Progressive narrowing can cause chronic stridor, sleep‑disordered breathing, or acute respiratory failure.
• Voice impairment: Persistent hoarseness or aphonia may affect communication, education, and employment.
• Recurrent infections: Papillomas trap mucus, promoting bacterial colonization and pneumonia.
• Pulmonary involvement: In rare cases, papillomas spread to the lungs, causing diffuse lesions, pneumothorax, or respiratory insufficiency.
• Malignant transformation: Although the papillomas are benign, about 1–5 % (higher in HPV‑11 infection) may evolve into squamous cell carcinoma, particularly in smokers or immunocompromised adults.
• Psychosocial impact: Chronic voice loss can lead to anxiety, depression, and social withdrawal.

---

When to Seek Emergency Care

---

References

• Mayo Clinic. Recurrent respiratory papillomatosis. 2023. https://www.mayoclinic.org
• Centers for Disease Control and Prevention. HPV Vaccine Recommendations. 2024. https://www.cdc.gov
• National Institutes of Health, National Cancer Institute. Human Papillomavirus (HPV) and RRP. 2022.
• Cleveland Clinic. Recurrent Respiratory Papillomatosis: Treatment Options. 2023.
• World Health Organization. Human papillomavirus (HPV) and diseases. 2023.
• Derkay CS, et al. Recurrent respiratory papillomatosis: review of the literature and clinical practice guidelines. *Laryngoscope*. 2021;131(4):877‑889.
• Huang SH, et al. Systemic bevacizumab for severe adult-onset RRP. *JAMA Otolaryngol Head Neck Surg*. 2022;148(9):845‑852.

```